ME1 Ann: Halucenex Phase II Clinical Trial Update - 12th Oct 2023, 9:25am

annb0t

annb0t

Top 20
ME1 Ann: Halucenex Phase II Clinical Trial Update
Price Sensitive: Y
Date: 12th Oct 2023, 9:25am

>>> Read announcement: Google: ME1 Market Announcements
 
You must log in or register to reply here.

Similar threads

annb0t
ME1 Ann: LOI for Sale of Sierra Sage and Halucenex to Panacea - 2nd Aug 2023, 9:18am
Replies
0
Views
56
annb0t
annb0t
annb0t
ME1 Ann: Quarterly Activities/Appendix 4C Cash Flow Report - 31st Oct 2023, 6:06pm
Replies
0
Views
81
annb0t
annb0t
annb0t
ME1 Ann: Update - Proposed issue of securities - ME1 - 31st Oct 2023, 9:57am
Replies
0
Views
63
annb0t
annb0t
annb0t
ME1 Ann: Prospectus - Bonus Options - 31st Oct 2023, 8:49am
Replies
0
Views
60
annb0t
annb0t
annb0t
ME1 Ann: Application for quotation of securities - ME1 - 30th Oct 2023, 6:40pm
Replies
0
Views
71
annb0t
annb0t
Top Bottom